Metropolitan Life Insurance Company (MetLife)’s John Wiley & Sons Class A WLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,895
Closed -$72.3K 2104
2024
Q1
$72.3K Sell
1,895
-181
-9% -$6.2K ﹤0.01% 1218
2023
Q4
$65.9K Sell
2,076
-502
-19% -$15.7K ﹤0.01% 1301
2023
Q3
$95.8K Buy
2,578
+331
+15% +$11.7K 0.01% 1041
2023
Q2
$76.5K Sell
2,247
-198
-8% -$7.21K ﹤0.01% 1167
2023
Q1
$94.8K Sell
2,445
-215
-8% -$9.16K ﹤0.01% 1011
2022
Q4
$107K Buy
2,660
+110
+4% +$4.6K ﹤0.01% 1022
2022
Q3
$95.8K Hold
2,550
﹤0.01% 1038
2022
Q2
$122K Sell
2,550
-239
-9% -$12.2K 0.01% 945
2022
Q1
$148K Sell
2,789
-15,164
-84% -$796K 0.01% 969
2021
Q4
$1.03M Sell
17,953
-947
-5% -$51.2K 0.01% 941
2021
Q3
$987K Sell
18,900
-245
-1% -$14K 0.01% 964
2021
Q2
$1.15M Buy
19,145
+10,920
+133% +$650K 0.02% 899
2021
Q1
$446K Buy
8,225
+411
+5% +$20.9K 0.01% 1494
2020
Q4
$357K Sell
7,814
-209
-3% -$7.57K 0.01% 1579
2020
Q3
$254K Sell
8,023
-434
-5% -$14.7K ﹤0.01% 1630
2020
Q2
$330K Sell
8,457
-3,190
-27% -$122K 0.01% 1491
2020
Q1
$437K Sell
11,647
-632
-5% -$26.5K 0.01% 1125
2019
Q4
$596K Buy
12,279
+2
+0% +$93 0.01% 1216
2019
Q3
$539K Sell
12,277
-586
-5% -$26.1K 0.01% 1237
2019
Q2
$590K Sell
12,863
-43
-0.3% -$1.96K 0.01% 1203
2019
Q1
$571K Sell
12,906
-21
-0.2% -$1.03K 0.01% 1216
2018
Q4
$607K Sell
12,927
-28
-0.2% -$1.51K 0.01% 1081
2018
Q3
$785K Buy
12,955
+28
+0.2% +$1.74K 0.01% 1065
2018
Q2
$807K Buy
12,927
+117
+0.9% +$7.77K 0.01% 1029
2018
Q1
$816K Buy
12,810
+52
+0.4% +$3.37K 0.01% 992
2017
Q4
$839K Sell
12,758
-29,158
-70% -$1.69M 0.01% 993
2017
Q3
$2.24M Sell
41,916
-221
-0.5% -$11.9K 0.01% 903
2017
Q2
$2.22M Buy
42,137
+267
+0.6% +$14K 0.02% 914
2017
Q1
$2.25M Sell
41,870
-98
-0.2% -$5.32K 0.02% 911
2016
Q4
$2.29M Buy
41,968
+14
+0% +$746 0.02% 926
2016
Q3
$2.17M Sell
41,954
-3,252
-7% -$178K 0.02% 930
2016
Q2
$2.36M Buy
45,206
+1,238
+3% +$62.5K 0.02% 878
2016
Q1
$2.15M Buy
43,968
+833
+2% +$36.4K 0.02% 870
2015
Q4
$1.94M Sell
43,135
-84
-0.2% -$4.16K 0.01% 907
2015
Q3
$2.16M Buy
43,219
+2,180
+5% +$113K 0.02% 881
2015
Q2
$2.23M Buy
41,039
+212
+0.5% +$12.3K 0.02% 927
2015
Q1
$2.5M Buy
40,827
+982
+2% +$60.3K 0.02% 817
2014
Q4
$2.36M Buy
39,845
+346
+0.9% +$19.9K 0.02% 905
2014
Q3
$2.22M Buy
39,499
+372
+1% +$22.2K 0.02% 912
2014
Q2
$2.37M Buy
39,127
+264
+0.7% +$15K 0.02% 922
2014
Q1
$2.24M Buy
38,863
+937
+2% +$52.1K 0.02% 929
2013
Q4
$2.09M Buy
37,926
+154
+0.4% +$7.79K 0.01% 952
2013
Q3
$1.8M Buy
37,772
+571
+2% +$25.5K 0.01% 987
2013
Q2
$1.49M Buy
+37,201
New +$1.44M 0.01% 1034

Other funds holding WLY

Metropolitan Life Insurance Company (MetLife)'s WLY Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of John Wiley & Sons Class A (WLY) in Q2 2024, closing a stake of 1,895 shares — an estimated $72.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in WLY in Q2 2013 and held it in 44 quarters. The position peaked at $2.5M in Q1 2015. 241 funds tracked by Wall St. Rank hold WLY as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining John Wiley & Sons Class A position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,895 John Wiley & Sons Class A shares in Q2 2024, an estimated $72.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in John Wiley & Sons Class A in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s John Wiley & Sons Class A position peaked at $2.5M in Q1 2015.
  • 241 funds tracked by Wall St. Rank held John Wiley & Sons Class A as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.